Yi Chen
Stock Analyst at HC Wainwright & Co.
(2.03)
# 2,899
Out of 4,883 analysts
505
Total ratings
38.48%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Yi Chen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LEXX Lexaria Bioscience | Maintains: Buy | $7 → $5 | $0.88 | +468.70% | 6 | Jul 1, 2025 | |
ZYXI Zynex | Reiterates: Buy | $8 | $2.69 | +197.40% | 23 | Jun 30, 2025 | |
LPCN Lipocine | Reiterates: Buy | $8 | $3.11 | +157.23% | 3 | Jun 27, 2025 | |
EDSA Edesa Biotech | Assumes: Buy | $5 | $2.07 | +141.46% | 1 | Jun 27, 2025 | |
ELDN Eledon Pharmaceuticals | Assumes: Buy | $9 | $3.06 | +194.12% | 1 | Jun 18, 2025 | |
EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $22 | $9.66 | +127.74% | 22 | May 29, 2025 | |
OCUL Ocular Therapeutix | Reiterates: Buy | $15 | $9.46 | +58.56% | 27 | May 29, 2025 | |
ICCM IceCure Medical | Reiterates: Buy | $2.5 | $1.01 | +147.52% | 21 | May 29, 2025 | |
NPCE NeuroPace | Initiates: Buy | $18 | $10.39 | +73.24% | 1 | May 28, 2025 | |
CLSD Clearside Biomedical | Maintains: Buy | $6 → $5 | $0.81 | +520.35% | 21 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $5.05 | +137.62% | 22 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.27 | +214.96% | 6 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $53 | $29.94 | +77.02% | 4 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $56.81 | +76.03% | 19 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.75 | +31.87% | 2 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $60 | $30.57 | +96.27% | 4 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $19.49 | +28.27% | 12 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.91 | +140.55% | 13 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $16.19 | +208.93% | 7 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $13.76 | +9.01% | 18 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $12.93 | +8.28% | 9 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.15 | +185.71% | 18 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $9.88 | +294.74% | 8 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $18.97 | +68.69% | 14 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.75 | +232.67% | 2 | Apr 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.40 | +194.12% | 1 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.34 | +123.88% | 14 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $9.39 | +70.39% | 10 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.69 | +155.86% | 19 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.88 | +316.67% | 4 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.86 | +248.88% | 1 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.29 | +249.65% | 23 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.90 | +244.83% | 16 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.19 | +119.44% | 19 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.95 | +217.12% | 13 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $8.62 | +294.43% | 10 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.58 | +414.05% | 20 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.43 | - | 10 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,250 → $1,125 | $4.94 | +22,693.12% | 18 | Jun 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.27 | +3,603.70% | 5 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.40 | +2,624.80% | 14 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.75 | - | 7 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $16.57 | +189.68% | 8 | Apr 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $640 | $15.82 | +3,945.51% | 5 | Apr 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $13.04 | +45.71% | 2 | Feb 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.44 | - | 2 | Apr 16, 2020 |
Lexaria Bioscience
Jul 1, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.88
Upside: +468.70%
Zynex
Jun 30, 2025
Reiterates: Buy
Price Target: $8
Current: $2.69
Upside: +197.40%
Lipocine
Jun 27, 2025
Reiterates: Buy
Price Target: $8
Current: $3.11
Upside: +157.23%
Edesa Biotech
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.07
Upside: +141.46%
Eledon Pharmaceuticals
Jun 18, 2025
Assumes: Buy
Price Target: $9
Current: $3.06
Upside: +194.12%
EyePoint Pharmaceuticals
May 29, 2025
Reiterates: Buy
Price Target: $22
Current: $9.66
Upside: +127.74%
Ocular Therapeutix
May 29, 2025
Reiterates: Buy
Price Target: $15
Current: $9.46
Upside: +58.56%
IceCure Medical
May 29, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.01
Upside: +147.52%
NeuroPace
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $10.39
Upside: +73.24%
Clearside Biomedical
May 23, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.81
Upside: +520.35%
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $5.05
Upside: +137.62%
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.27
Upside: +214.96%
May 15, 2025
Maintains: Buy
Price Target: $51 → $53
Current: $29.94
Upside: +77.02%
May 15, 2025
Reiterates: Buy
Price Target: $100
Current: $56.81
Upside: +76.03%
May 13, 2025
Reiterates: Buy
Price Target: $30
Current: $22.75
Upside: +31.87%
May 12, 2025
Maintains: Buy
Price Target: $57 → $60
Current: $30.57
Upside: +96.27%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $19.49
Upside: +28.27%
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $2.91
Upside: +140.55%
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $16.19
Upside: +208.93%
May 2, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $13.76
Upside: +9.01%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $12.93
Upside: +8.28%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.15
Upside: +185.71%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $9.88
Upside: +294.74%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $18.97
Upside: +68.69%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.75
Upside: +232.67%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.40
Upside: +194.12%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Apr 7, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $9.39
Upside: +70.39%
Apr 4, 2025
Reiterates: Buy
Price Target: $12
Current: $4.69
Upside: +155.86%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.88
Upside: +316.67%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.86
Upside: +248.88%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.29
Upside: +249.65%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $2.90
Upside: +244.83%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $3.19
Upside: +119.44%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $0.95
Upside: +217.12%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $8.62
Upside: +294.43%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.58
Upside: +414.05%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $5,250 → $1,125
Current: $4.94
Upside: +22,693.12%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.27
Upside: +3,603.70%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.40
Upside: +2,624.80%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.75
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $16.57
Upside: +189.68%
Apr 1, 2021
Maintains: Buy
Price Target: $480 → $640
Current: $15.82
Upside: +3,945.51%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $13.04
Upside: +45.71%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.44
Upside: -